InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,584.54
(
-0.88%
)
US TECH 100
19,681.20
(
-2.17%
)
Dow Jones
39,753.75
(
0.08%
)
Brent Oil
85.30
(
0.22%
)
Bitcoin
57,551.30
(
0.35%
)
Post# of 252581
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 120031
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 237498

Wednesday, 03/23/2022 9:38:11 AM

Wednesday, March 23, 2022 9:38:11 AM

Post# of 252581
LBPS +46% on purportedly-positive phase-1/2 data in RCC:

https://finance.yahoo.com/news/4d-pharma-announces-positive-interim-110000800.html

Part B of the study has to date enrolled 20 patients with RCC, of which four out of the first 16 evaluable patients have achieved clinical benefit, each having achieved at least 6 months of stable disease.

In other words, none of the 20 patents with RCC has had an objective response! Caveat emptor.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up